Literature DB >> 28257622

Case report: two human Streptococcus suis infections in Borneo, Sabah, Malaysia.

Giri Shan Rajahram1,2, Ahneez Abdul Hameed3, Jayaram Menon4,5, Timothy William6, Paul Anantharajah Tambyah7, Tsin Wen Yeo8,9,10.   

Abstract

BACKGROUND: Streptococcus Suis (S.suis) is increasingly being recognised as a potentially preventable emerging zoonotic infection in humans with a global distribution. It is a major cause of meningitis especially among those in contact with pigs and has also been associated with a toxic shock syndrome. CASE PRESENTATIONS: We report the first two human cases from Sabah, Borneo, Malaysia which expands the global reach of this important pathogen. Here, we illustrate their epidemiological risk factors, clinical presentation and resulting sequelae of both patients.
CONCLUSION: The continued public health threat of zoonotic infections such as S.suis, highlights the need for accurate epidemiological surveillance, regulation of pig farming, slaughtering and continued advocacy of best practices for pork preparation and consumption.

Entities:  

Keywords:  Case report; Meningitis; Sabah; Streptococcus suis

Mesh:

Year:  2017        PMID: 28257622      PMCID: PMC5336690          DOI: 10.1186/s12879-017-2294-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Streptococcus suis (S.suis) is a porcine zoonotic infection which is increasingly recognised. Meningitis and septicaemia have been described as the most common clinical syndromes [1]. Since the first reported human case in Denmark, increasing numbers have been reported worldwide [2]. In South East Asia, Thailand and Vietnam have reported the largest number of cases with sporadic reports from Singapore, Philippines and Laos [2]. To date, there have not been any cases reported from Malaysia or Indonesia partly because of the limited pig rearing due to cultural reasons. We report two cases from Sabah, Borneo, Malaysia.

Case report

The first patient was a 41-year-old previously healthy man who presented with 2 day history of fever, headache, vomiting, neck pain and behavioural change. He reared four pigs at home and had daily contact with them. On examination, he was confused and disorientated, with a Glasgow Coma Scale (GCS) 7/15, hypotensive with a blood pressure of 89/57 mmHg, and had meningeal signs, however there was no rash noted. He was intubated for airway protection, started on noradrenaline, ceftriaxone and acyclovir. Blood tests indicated leucocytosis (13.7 × 109 white blood cell/L), neutrophilia (12.63 × 109 neutrophils/L), lymphopenia (0.72 × 109 lymphocytes/L), elevated C-reactive protein (320 mg/L), and hypoalbuminemia (28 g/L). Contrast enhanced computed tomography of the brain and transthoracic echocardiogram were normal. Lumbar puncture done 12 h after admission and initial antibiotic administration showed an opening pressure of 27 cmH20 and the cerebrospinal fluid (CSF) was noted to be cloudy with a protein level of 2.16 g/L, a glucose level of 1.98 mmol/L (concomitant serum glucose was 7.6 mmol/L), and 95 leukocytes/μL (30% neutrophils and 65% lymphocytes). CSF gram stain and culture did not reveal any organism however blood cultures after 3 h of incubation were positive for gram positive cocci in chains. Culture specimens were plated on blood agar and after 18 h of incubation in 37 °C under aerobic conditions, the growth showed alpha haemolytic colonies which were catalase negative. These colonies were identified using matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) VITEK® MS MALDI-TOF MS (bioMériux) as Streptococcus suis with a 99.9% probability score. Antibiotic susceptibility testing was carried out according to the Clinical Science Laboratory Institute [3] testing recommendation using the Kirby-Bauer method. The strain was sensitive to penicillin and ceftriaxone the minimal inhibitory concentration (MIC) of penicillin and ceftriaxone were identified by epsilometer test (E-test bioMériux) with an MIC <0.12 ug/ml and <1.0ug/ml respectively). The patient was extubated after 48 h and continued to make a good clinical recovery with antibiotics and completed a two week course of ceftriaxone. However, in the second week of admission he developed tinnitus with reduced hearing in both ear associated with vertigo, loss of balance and nausea. He was scheduled for a pure tone audiometry on clinic follow up upon discharge however defaulted his appointment and we do not have any record of permanent eighth nerve damage. The second patient was a 44-year-old man, presented with a 2 day history of fever with chills and rigors associated with headache and vomiting. On examination he was alert and conscious with no signs of meningism. He had no fever on admission, the blood pressure was 124/68 mmHg and heart rate 81 beats per minute. Systemic examination was unremarkable. He worked as a butcher in local market handling pork and had injured his thumb while slaughtering a pig two days prior to onset of symptoms. Blood tests showed leucocytosis (35.4 × 109 white blood cell/L), neutrophilia (33.04 × 109 neutrophils/L), lymphopenia (0.70 × 109 lymphocytes/L), elevated C-reactive protein (226.8 mg/L), and hypoalbuminemia (29 g/L). Blood culture on admission and antibiotic susceptibility testing performed by methods described above was positive for Streptococcus suis which was sensitive to penicillin. Lumbar puncture performed 48 h after admission was normal with no white blood cells and normal glucose and protein. His echocardiogram also did not show any evidence of endocarditis. He completed two weeks of intravenous penicillin G and made complete recovery on discharge without any residual neurological or otological deficits.

Discussion

Consistent with previous reports [1, 2, 4] both our patients had significant exposure to pigs prior to developing infection. In Asia, besides direct trauma as with our second patient, it is increasing recognised that suboptimal preparation and consumption of pork and its organs may increase the risk of acquiring this disease [1, 2, 4]. The first patient presented with meningitis associated with bacteraemia and developed hearing loss and vestibular symptoms during the course of admission. This is consistent with previous reports of S. suis meningitis with labyrinthitis [5] and sensory neural hearing loss occurring in up to 2/3rd of patients with a guarded prognosis for recovery [4]. The use of dexamethasone therapy in association to reducing hearing loss is controversial, with one study showing reduction in severe hearing loss [4] and a subsequent case series demonstrating hearing loss continued to occur despite therapy [6]. As with other forms of bacterial meningitis, the best outcomes are likely to be obtained by early recognition and rapid administration of parenteral antibiotics, combined administration of dexamethasone patients with a history of porcine exposure, and in regions with a high prevalence of S.suis meningitis [7]. Referral to the Otorhinolaryngologist for audiometry and vestibular testing may be needed including early evaluation for cochlear implant [8]. Although meningitis is the most common described presentation of S.suis infection, sepsis, uveitis, endoptahlmitis, endocarditis, arthritis and spondylodiscitis have all been previously reported [1, 2]. Of note, large outbreaks in China have described streptococcal toxic shock syndrome (STSS) associated with S. suis infection with rapid clinical deterioration including purpura fulminans and high mortality [9, 10]. While this syndrome has not been recognised outside of China, there is a concern that limited diagnostic resources and a lack of accessibility to healthcare may be the reason why this is so in other parts of Asia. To date, 29 serotypes S.suis have been described [11]. The majority of human cases have been attributed to serotype 2 with also some sporadic cases from other serotypes, mainly serotype 1410. Reliable multiplex PCR methods are replacing traditional biochemical based methods in detecting these serotype [12], this coupled with multilocus sequence typing (MLST) this has led to better epidemiological characterization and improved understanding virulence patterns of this organism [11]. Unfortunately, these were not available in our regional hospital as the need for specialised expertise and funding limits such testing to regional and national reference laboratories or in an academic setting.

Conclusion

In summary our cases illustrate the common clinical presentation and sequelae associated with Streptococcus suis infection. Although it is a common zoonotic infection in certain parts of Asia, the true burden of illness in Malaysia in not know. The continued public health threat of zoonotic infections such as S.suis, highlights the need for accurate epidemiological surveillance, regulation of pig farming, slaughtering and continued advocacy of best practices for pork preparation and consumption.
  9 in total

1.  Streptococcus suis meningitis in adults in Vietnam.

Authors:  Nguyen Thi Hoang Mai; Ngo Thi Hoa; Tran Vu Thieu Nga; Le Dieu Linh; Tran Thi Hong Chau; Dinh Xuan Sinh; Nguyen Hoan Phu; Ly Van Chuong; To Song Diep; James Campbell; Ho Dang Trung Nghia; Tran Ngoc Minh; Nguyen Van Vinh Chau; Menno D de Jong; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar; Constance Schultsz
Journal:  Clin Infect Dis       Date:  2008-03-01       Impact factor: 9.079

2.  Streptococcus suis serotyping by a new multiplex PCR.

Authors:  Anusak Kerdsin; Yukihiro Akeda; Rujirat Hatrongjit; Unchaya Detchawna; Tsutomu Sekizaki; Shigeyuki Hamada; Marcelo Gottschalk; Kazunori Oishi
Journal:  J Med Microbiol       Date:  2014-04-02       Impact factor: 2.472

3.  Streptococcus suis infection: clinical features and diagnostic pitfalls.

Authors:  Kobkiat Donsakul; Charungthai Dejthevaporn; Rawiphan Witoonpanich
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

Review 4.  Streptococcus suis: an emerging human pathogen.

Authors:  Heiman F L Wertheim; Ho Dang Trung Nghia; Walter Taylor; Constance Schultsz
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

5.  Epidemiology, clinical manifestations, and outcomes of Streptococcus suis infection in humans.

Authors:  Vu Thi Lan Huong; Ngo Ha; Nguyen Tien Huy; Peter Horby; Ho Dang Trung Nghia; Vu Dinh Thiem; Xiaotong Zhu; Ngo Thi Hoa; Tran Tinh Hien; Javier Zamora; Constance Schultsz; Heiman Frank Louis Wertheim; Kenji Hirayama
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

Review 6.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Jianguo Xu; Mariela Segura; Marcelo Gottschalk
Journal:  Emerg Microbes Infect       Date:  2014-06-18       Impact factor: 7.163

7.  Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2.

Authors:  Jiaqi Tang; Changjun Wang; Youjun Feng; Weizhong Yang; Huaidong Song; Zhihai Chen; Hongjie Yu; Xiuzhen Pan; Xiaojun Zhou; Huaru Wang; Bo Wu; Haili Wang; Huamei Zhao; Ying Lin; Jianhua Yue; Zhenqiang Wu; Xiaowei He; Feng Gao; Abdul Hamid Khan; Jian Wang; Guo-Ping Zhao; Yu Wang; Xiaoning Wang; Zhu Chen; George F Gao
Journal:  PLoS Med       Date:  2006-04-11       Impact factor: 11.069

Review 8.  Streptococcus suis Meningitis: A Systematic Review and Meta-analysis.

Authors:  Anusha van Samkar; Matthijs C Brouwer; Constance Schultsz; Arie van der Ende; Diederik van de Beek
Journal:  PLoS Negl Trop Dis       Date:  2015-10-27

9.  Profile of patients assessed for cochlear implants.

Authors:  Maria Helena de Magalhães Barbosa; Felippe Felix; Marcia Gonçalves Ribeiro; Shiro Tomita; Cintia Pinheiro; Monica Machado Baptista
Journal:  Braz J Otorhinolaryngol       Date:  2014-06-11
  9 in total
  8 in total

Review 1.  Sociocultural Factors Influencing Human Streptococcus suis Disease in Southeast Asia.

Authors:  Anusak Kerdsin; Mariela Segura; Nahuel Fittipaldi; Marcelo Gottschalk
Journal:  Foods       Date:  2022-04-20

2.  Update on Streptococcus suis Research and Prevention in the Era of Antimicrobial Restriction: 4th International Workshop on S. suis.

Authors:  Mariela Segura; Virginia Aragon; Susan L Brockmeier; Connie Gebhart; Astrid de Greeff; Anusak Kerdsin; Mark A O'Dea; Masatoshi Okura; Mariette Saléry; Constance Schultsz; Peter Valentin-Weigand; Lucy A Weinert; Jerry M Wells; Marcelo Gottschalk
Journal:  Pathogens       Date:  2020-05-14

3.  PmtA functions as a ferrous iron and cobalt efflux pump in Streptococcus suis.

Authors:  Chengkun Zheng; Mengdie Jia; Miaomiao Gao; Tianyu Lu; Lingzhi Li; Pingping Zhou
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

4.  A Streptococcus suis infection causing pneumonia in Indonesia: A case report.

Authors:  Cheria Cahyaningtyas; Lisa Tenriesa Muslich; Firdaus Hamid; Andi Rofian Sultan; Rizalinda Sjahril; Muhammad Nasrum Massi; Mochammad Hatta; Baedah Madjid
Journal:  Radiol Case Rep       Date:  2022-09-15

5.  The global emergence of a novel Streptococcus suis clade associated with human infections.

Authors:  Xingxing Dong; Yanjie Chao; Yang Zhou; Rui Zhou; Wei Zhang; Vincent A Fischetti; Xiaohong Wang; Ye Feng; Jinquan Li
Journal:  EMBO Mol Med       Date:  2021-06-17       Impact factor: 12.137

6.  Combination Therapy Strategies Against Multiple-Resistant Streptococcus Suis.

Authors:  Yang Yu; Jin-Tao Fang; Mei Zheng; Qing Zhang; Timothy R Walsh; Xiao-Ping Liao; Jian Sun; Ya-Hong Liu
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

7.  Effects of Low-Dose Antibiotics on Gut Immunity and Antibiotic Resistomes in Weaned Piglets.

Authors:  Qi Hu; Cong Liu; Du Zhang; Ru Wang; Linlin Qin; Qin Xu; Lianqiang Che; Fei Gao
Journal:  Front Immunol       Date:  2020-06-10       Impact factor: 7.561

8.  Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.

Authors:  Lingli Huang; Haiyang Zhang; Mei Li; Ijaz Ahmad; Yulian Wang; Zonghui Yuan
Journal:  BMC Vet Res       Date:  2018-10-24       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.